Development and use of evidence-based clinical practice guidelines for thyroid disease

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 3, 2002, Pages 795-817

  Belin, Ruth M ^a   Ladenson, Paul W ^a   Robinson, Karen A ^b   Powe, Neil R ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MEDICAL EDUCATION; MEDICAL LITERATURE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; REVIEW; THYROID DISEASE; VALIDATION PROCESS;

ENDOCRINOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES; THYROID DISEASES;

EID: 0036713004     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00023-3     Document Type: Review

References (77)

1. Definition of key terms
2. American Thyroid Association guidelines for detection of thyroid dysfunction
3. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer
4. AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma
5. Developing valid cost effectiveness guidelines: A methodological report from the North of England evidence based guideline development project
6. Summary
7. Practice guidelines developed by specialty societies: The need for critical appraisal
8. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature
9. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism
10. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders
11. Newborn screening for congenital hypothyroidism: Recommended guidelines
12. Screening for congenital hypothyroidism
13. Screening for thyroid disease: An update
14. Screening for thyroid disease
15. Subclinical hypothyroidism during pregnancy: Position statement from the American Association of Clinical Endocrinologists
16. Treatment guidelines for patients with hyperthyroidism and hypothyroidism
17. AACE clinical practice guidelines for the diagnosis and management of thyroid nodules
18. Screening for thyroid cancer: Background paper
19. Screening for thyroid cancer
20. Clinical pathways for general surgeons: Partial or total thyroidectomy
21. Critical care pathway development: The way forward
22. The effect of clinical pathway implementation on total hospital costs for thyroidectomy and parathyroidectomy
23. Management of the nontoxic multinodular goiter: A North American Study
24. Subclinical hypothyroidism
25. The effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature
26. Screening for mild thyroid failure at the periodic health examination
27. Current trends in the management of Graves' disease
28. Current trends in the management of well differentiated papillary thyroid carcinoma
29. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States
30. Do consensus conferences work? A process evaluation of the NIH consensus development program
31. The promise and problems of meta-analysis
32. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts
33. Meta-analyses and large randomized, controlled trials
34. The medical review article revisited: Has the science improved?
35. Preface
36. Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations
37. Decision analysis in endocrinology and metabolism
38. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services
39. Clinical guidelines: Developing guidelines
40. Subclinical thyroid disease: A clinician's perspective
41. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer
42. Current methods of the US Preventive Services Task Force: A review of the process
43. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
44. The methodologic partnership of effectiveness reviews and cost-effective analysis
45. Clinical guidelines: Using clinical guidelines
46. Barriers physicians face when using asthma practice guidelines
47. Why don't physicians follow clinical practice guidelines? A framework for improvement
48. Reasons physicians do not follow clinical practice guidelines
49. The impact of practice guidelines in the management of Barrett's esophagus: A national prospective cohort study of physicians
50. A method for guideline development: Assessing practical feasibility and adaptation of thyroid nodule guidelines
51. Despite financial penalties, French physicians' knowledge of regulatory practice guidelines is poor
52. Effect of early referral to an endocrinologist on efficiency and cost of evaluation and development of treatment plan in patients with thyroid nodules
53. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: A national survey of endocrine surgeons
54. Including practice data to improve evidence-based guidelines: Example of guidelines on the management of thyroid nodules
55. Clinical and socioeconomic predispositions to complicated thyrotoxicosis: A predictable and preventable syndrome?
56. Developing and implementing computerized protocols for standardization of clinical decisions
57. Sharable computer-based clinical practice guidelines: Rationale, obstacles, approaches, and prospects
58. Evaluation informatics applications: Clinical decision support systems literature review
59. Clinical benchmarking enabled by the digital health record
60. Relationships between authors of clinical practice guidelines and the pharmaceutical industry
61. Evidence-based and evidence-biased medicine
62. Management of mild hypertension: Which guidelines to follow?
63. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: How quickly do guidelines become outdated?
64. Development and aftercare of clinical guidelines
65. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
66. Efficient evaluation of thyroid nodules by primary care providers and thyroid specialists